Loading clinical trials...
Loading clinical trials...
Protection Against Severe Coronavirus Disease 2019 Following in Patients With Multiple Sclerosis Statified According to Disease Modifying Treatment
Conditions
Locations
1
Belgium
Nationaal MS center
Melsbroek, Vlaams Brabant, Belgium
Start Date
March 1, 2020
Primary Completion Date
December 1, 2022
Completion Date
April 1, 2023
Last Updated
November 18, 2023
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
National MS Center Melsbroek
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions